GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Estrella Immunopharma Inc (NAS:ESLA) » Definitions » PB Ratio

ESLA (Estrella Immunopharma) PB Ratio : 6.78 (As of Oct. 31, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Estrella Immunopharma PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-10-31), Estrella Immunopharma's share price is $0.7999. Estrella Immunopharma's Book Value per Share for the quarter that ended in Jun. 2024 was $0.12. Hence, Estrella Immunopharma's PB Ratio of today is 6.78.

The historical rank and industry rank for Estrella Immunopharma's PB Ratio or its related term are showing as below:

ESLA' s PB Ratio Range Over the Past 10 Years
Min: 0   Med: 0   Max: 11.48
Current: 6.9

During the past 4 years, Estrella Immunopharma's highest PB Ratio was 11.48. The lowest was 0.00. And the median was 0.00.

ESLA's PB Ratio is ranked worse than
82.58% of 1269 companies
in the Biotechnology industry
Industry Median: 2.49 vs ESLA: 6.90

Back to Basics: PB Ratio


Estrella Immunopharma PB Ratio Historical Data

The historical data trend for Estrella Immunopharma's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Estrella Immunopharma PB Ratio Chart

Estrella Immunopharma Annual Data
Trend Jun21 Jun22 Jun23 Jun24
PB Ratio
- - - 8.90

Estrella Immunopharma Quarterly Data
Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 4.32 5.32 8.90

Competitive Comparison of Estrella Immunopharma's PB Ratio

For the Biotechnology subindustry, Estrella Immunopharma's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Estrella Immunopharma's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Estrella Immunopharma's PB Ratio distribution charts can be found below:

* The bar in red indicates where Estrella Immunopharma's PB Ratio falls into.



Estrella Immunopharma PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Estrella Immunopharma's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Jun. 2024)
=0.7999/0.118
=6.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Estrella Immunopharma  (NAS:ESLA) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Estrella Immunopharma PB Ratio Related Terms

Thank you for viewing the detailed overview of Estrella Immunopharma's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Estrella Immunopharma Business Description

Traded in Other Exchanges
N/A
Address
5858 Horton Street, Suite 170, Emeryville, CA, USA, 94608
Estrella Immunopharma Inc is a preclinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer.

Estrella Immunopharma Headlines